Stem Cell: market research reports

... of “industrialized drug discovery.” This report discusses: Development of the HCA field from the commercial, scientific, and technological perspectives Technologies that underlie HCA and the full range of systems that are available today Applications of ...  |  read more...

... bank and the stem cells are immediately available for use in medical treatments, such as future therapies requiring repair or replacement of damaged heart tissues. An infant's cord blood offers the most ideal option for ...  |  read more...

... factors include government policies relating to the industry, tax policies, laws and regulations, trade restrictions and tariffs etc. The economic factors relate to changes in the wider economy such as economic growth, interest rates, exchange ...  |  read more...

... nearly 35% of the market and will likely witness a higher growth rate in the upcoming years, in comparison with Asia-Pacific. While US accounts for the highest share of the global market value on a ...  |  read more...

... 2010, and projections of compound annual growth rates (CAGRs) through 2015 A breakdown of technology platforms at the forefront of cell-based assays, including flow cytometry, microscopy and image-based, laser capture microdissection and tissue microarrays, in ...  |  read more...

... researchers in the US are coming up with new outcomes that will make a paradigm shift in drug discovery and the medicine world. The country has witnessed some major achievements in the treatment of diseases ...  |  read more...

... Latin and South America represent one of the faster-growing geographical segments for stem cell anticancer therapies. This region was valued at nearly $55 million in 2010 and is expected to increase at a 15.1% compound ...  |  read more...

... Stem Cell Therapies and Gene Therapies”, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection, Cardiovascular Disease and Oncology ...  |  read more...

... as Advanced Cell Technology, Inc., Athersys, Inc., BioE, Inc., Cryo-Cell International, Inc., Cytori Therapeutics, Inc., Edstrom Biosciences, Inc., Geron Corporation, International Stem Cell Corporation, Neuralstem, Inc., NeuroGeneration, Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ...  |  read more...

... making them highly suited for the development of cellular therapeutics. This report details the current status of the cellular therapeutics marketplace, products that are commercialized, market potential, clinical trials pipeline and characterization of this pipeline ...  |  read more...

... cardiovascular disease. Scope Data and information on the most commonly reprocessed market assessment of Stem Cell Therapy in cardiovascular disease Reasons to buy Develop business strategies by understanding the trends and developments that are driving ...  |  read more...

... differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and ...  |  read more...